Homodimer 99mTc-HYNIC-E(SSSLTVPWY)2 peptide improved HER2-overexpressed tumor targeting and imaging
Author:
Funder
Mazandaran University of Medical Sciences
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s12032-022-01798-6.pdf
Reference57 articles.
1. Lipton A, Leitzel K, Ali SM, Carney W, Platek G, Steplewski K, et al. Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression-free survival in patients with HER2-positive metastatic breast cancer receiving lapatinib monotherapy. Cancer. 2011;117(21):5013–20. https://doi.org/10.1002/cncr.26101.
2. Marker KM, Zavala VA, Vidaurre T, Lott PC, Vásquez JN, Casavilca-Zambrano S, et al. Human epidermal growth factor receptor 2-positive breast cancer is associated with Indigenous American ancestry in Latin American women. Cancer Res. 2020;80(9):1893–901. https://doi.org/10.1158/0008-5472.can-19-3659.
3. Nahta R. Human epidermal growth factor receptor 2-targeted therapies in breast cancer. Expert Opin Biol Ther. 2013;13(7):949–52. https://doi.org/10.1517/14712598.2013.789497.
4. Song X, Sun K, Hu J, Zhou J. Suppression of human epidermal growth factor receptor 2 via interference increases the chemosensitivity of ovarian carcinoma. Oncol Lett. 2016;11(5):3028–32. https://doi.org/10.3892/ol.2016.4341.
5. Roviello G, Aprile G, D’Angelo A, Iannone LF, Roviello F, Polom K, et al. Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand? Gastric Cancer. 2021;24(4):765–79. https://doi.org/10.1007/s10120-021-01182-9.
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Meet the Editorial Board Member;Current Medicinal Chemistry;2023-09
2. Evaluation of homodimer 99mTc-HYNIC-E(SSSLTVPWY)2 peptide on HER2-over expressed breast cancer cells;Medicinal Chemistry Research;2023-05-06
3. The preclinical study of 177Lu-DOTA-LTVSPWY as a potential therapeutic agent against HER2 overexpressed cancer;Annals of Nuclear Medicine;2023-04-28
4. A Novel Homodimer Peptide–Drug Conjugate Improves the Efficacy of HER2-Positive Breast Cancer Therapy;International Journal of Molecular Sciences;2023-02-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3